The neuro-pathogenic mechanism(s) underlying HIV-associated neurocognitive disorders are mostly unknown. HIV-infected macrophages and microglial cells play a crucial role and the metabolic fate of L-arginine may be highly relevant for microglia activation. In this context Arginase (ARG), which uses L-arginine as substrate, can be on the same time a target and source of oxidative stress and inflammation. In the present study, we investigated whether Integrase Strand Transfer Inhibitors (INSTIs) share with the other antiretroviral drugs the ability to inhibit ARG activity. We used the previously validated cell model, namely the human microglia cell line (CHME-5), as well as the computational chemistry approach. Furthermore, here we characterized the activity of purified human ARG in a cell-free in vitro system, and investigated the effects of INSTIs in this newly validated model. Overall evidence shows that Dolutegravir, Raltegravir and Elvitegravir inhibit ARG activity

Lisi, L., Pizzoferrato, M., Miscioscia, F. T., Topai, A., Navarra, P., Interactions between Integrase Inhibitors and human Arginase 1, <<JOURNAL OF NEUROCHEMISTRY>>, 2017; (APRILE): N/A-N/A. [doi:10.1111/jnc.14039] [http://hdl.handle.net/10807/98364]

Interactions between Integrase Inhibitors and human Arginase 1

Lisi, Lucia
Primo
;
Pizzoferrato, Michela
Secondo
;
Navarra, Pierluigi
Ultimo
2017

Abstract

The neuro-pathogenic mechanism(s) underlying HIV-associated neurocognitive disorders are mostly unknown. HIV-infected macrophages and microglial cells play a crucial role and the metabolic fate of L-arginine may be highly relevant for microglia activation. In this context Arginase (ARG), which uses L-arginine as substrate, can be on the same time a target and source of oxidative stress and inflammation. In the present study, we investigated whether Integrase Strand Transfer Inhibitors (INSTIs) share with the other antiretroviral drugs the ability to inhibit ARG activity. We used the previously validated cell model, namely the human microglia cell line (CHME-5), as well as the computational chemistry approach. Furthermore, here we characterized the activity of purified human ARG in a cell-free in vitro system, and investigated the effects of INSTIs in this newly validated model. Overall evidence shows that Dolutegravir, Raltegravir and Elvitegravir inhibit ARG activity
Inglese
Lisi, L., Pizzoferrato, M., Miscioscia, F. T., Topai, A., Navarra, P., Interactions between Integrase Inhibitors and human Arginase 1, <<JOURNAL OF NEUROCHEMISTRY>>, 2017; (APRILE): N/A-N/A. [doi:10.1111/jnc.14039] [http://hdl.handle.net/10807/98364]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/98364
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact